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Time matters: a call to prioritise brain health 
This article summarises the content of a policy report recommending a proactive 
approach to neurodegenerative disease management. Nurses are reminded of the 
importance of the contribution of nurses to policy making and implementation of policy. 
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It is well recognised that neurological conditions need to become more of a priority at 
Government or commissioning levels in the UK (Thomas, 2016) and that, often, there are 
variations in the quality of services provided to patients with neurological conditions (Fuller 
et al, 2018). For some conditions, campaigns for early disease detection, the timely provision 
of interventions and the communication of important public health messages have shown 
great success (Hughes-Hallett et al, 2016). However, the same is not true for most conditions 
of the brain (Giovannoni et al, 2019). Brain health is slowly becoming better understood, but 
much still needs to be done to manage the projected increase in the numbers of people 
affected by progressive neurodegenerative diseases. Greater education is also needed, both 
for the patients with these conditions and the health professionals caring for them. 
 
Nurses’ contribution to policy making 
Nurses have a key role to play in both the design and implementation of national policy 
documents and guidelines. Owing to the close relationships nurses share with their patients, 
their perspective is unique, particularly with regard to insight into the problems faced daily 
by people with long- term neurological conditions. Nurses have an understanding of inter-
family dynamics, practical issues, psycho-social concerns and financial stresses and, 
therefore, should be involved in policy development to add that ‘real world’ aspect. 
Strong, co-ordinated nurse leadership is essential, not only in the development of national 
policy but in the subsequent planning for the delivery of recommendations for service 
improvements. Health promotion messages will be delivered and implemented by nurses;, 
resources are often administered by nursing teams,; and nursing records are often used for 
research purposes and data collection. 
2020 marked the bi-centennial celebration of Florence Nightingale’s birth, and many tributes 
have been paid to the ‘philosophical founder of modern nursing’ (Peate, 2019). It is 
interesting to reflect that records show all of the roles listed above – —health promotion, 
administration of resources and data collection – —were all regularly performed and 
championed by Florence Nightingale. Therefore, if offered the opportunity, nurses should be 
prepared to contribute to the development of national and international policy documents and 
to engage fully in their implementation and audit. 
 
Time matters: the Think Brain Health report 
In 2018, I was invited to join a working party, made up of an independent group of 
international scientists, clinicians and health provision professionals, to develop a policy 
report calling for a more proactive approach to the detection and management of 







targeting the general public, health professionals, policymakers and regulators, to 
propose a preventive approach to neurodegenerative disease. Alzheimer’s disease (AD) and 
Parkinson’s disease (PD) are the focus of the report, because they are the two most 
common neurodegenerative diseases: PD affects more than 6 million people worldwide 
(Dorsey et al, 2018); AD is the most common cause of dementia, which affects 
approximately 50 million people (World Health Organization (WHO), 2020). However, the 
principles underlying the recommendations can be applied to the majority of long-term 
neurodegenerative conditions. 
 
What follows is a summary of the published report and the resulting policy 
recommendations. Time matters: a call to prioritize brain health summarises published 
evidence and the consensus findings of the international multidisciplinary expert group, 
including clinicians, researchers and representatives from patient advocacy and professional 
groups. It presents an expert, evidence-based position for policy recommendations that 
encourage individuals to participate actively in prioritising their own brain health. It 
challenges policymakers, researchers, funding bodies and health professionals to 
collaborate in planning for the healthcare structures of the future—and it is important 
that nurses are part of this. 
 
The report is supported by a campaign website—https://www.thinkbrainhealth.org/— 
and a successful conference series in November 2020, entitled Think Brain Health—a 
policy, clinical and research challenge, covered some of the issues raised within the report. 
All the conference presentations can be viewed online: 
https://www.thinkbrainhealth.org/events/ 
 
The six chapters cover the wide-ranging issues to be considered by health 
professionals, policymakers and patients alike. The detail and high-quality deliberation of 
evidence, combined with expert opinion, allows the reader a useful insight into the breadth 
of clinical topics linked to PD and AD and makes the document a useful resource for 
neuroscience practitioners. The chapters are as follows: 
• Chapter 1: The impact of neurodegenerative diseases 
• Chapter 2: The course of neurodegeneration 
• Chapter 3: Risk factors for neurodegeneration 
• Chapter 4: Strategies to identify people at risk of the disease 
• Chapter 5: Management following neurodegenerative disease diagnosis 
• Chapter 6: Actions to avert a future crisis. 
The detail of the report can be condensed into the following conclusion and policy 
recommendations: 
 
• The key risk factors for AD and PD, both modifiable and non-modifiable, should be 
understood by health practitioners and the general public. By implementing beneficial 
behaviours and potential lifestyle changes, brain health can be improved, just as these 
behaviours have been shown to improve health in other conditions, such as cardiovascular 
disease 
• What is good for the heart is generally good for the brain is an important public health 







• Primary prevention strategies that encourage modification of behaviour are not the only 
potential interventions. Population screening or health-check programmes that aim to 
detect disease early have been successful in some areas of medicine (e.g. cancer and heart 
disease) and should be considered in neurological disease 
• To prepare for future advances, the authors recommend some specific areas for research, 
including continuing the search for effective diagnostic tools, biomarkers, drug targets and 
treatments. If associations between brain diseases and some of their causative factors could 
be identified, this could speed up the identification of drug targets 
• Wearable technology may be useful in tracking an individual’s disease course and enabling 
personalised healthcare 
• The recommendations should help those tasked with organising health services to decide 
how best to prepare for the advent of national programmes that facilitate earlier detection 
and intervention of neurodegenerative diseases, such as AD and PD 
• All interested stakeholders need to work together for the common goal of improved 
healthcare for neurodegenerative diseases. This can be achieved far more effectively 
together than separately. 
Policy recommendations 
Health promotion recommendations 
The message ‘what is good for your heart is generally good for your brain’ needs to be 
widely communicated and understood. Therefore, policymakers and public health bodies 
that provide health information to the general public should act on the recommendations 
below which are listed in the report and on the Think Brain Health website (Alzheimer’s 
Research UK, 2020): 
• Protect and provide the public health budgets to improve public understanding of how to 
promote brain health and promote a positive approach that helps to prevent 
neurodegenerative diseases 
• Encourage behaviours at all ages that help to improve brain health, such as healthy eating 
and taking adequate exercise 
• Provide a supportive environment, including national guidance and legislation when 
appropriate, that empowers individuals to make important lifestyle changes 
• Prepare for the likely growth in the demand for genetic testing by people who want to 
understand their risk of a neurodegenerative disease. This should involve establishing 
rigorous support systems and processes, including training health professionals to 
counsel individuals who have undergone testing and to share their test result in an ethical 
and regulated way 
• Provide access to available and effective treatments in a timely manner. 
Clinical recommendations 
Health professionals and administrators will continue to play a key role in the 
management of people with, or at risk of, a neurodegenerative disease and should act on the 
recommendations below: 
• Refer anyone with a suspected neurodegenerative disease to specialist, multidisciplinary 
services, if they are available 
• Provide follow-up to individuals in the form of multidisciplinary services to provide 
ongoing, widely accessible holistic care, including prevention information, treatment 








Researchers and organisations that fund scientific research need to help health professionals 
and society to avert a future health crisis. Further work is needed to develop treatments for 
neurodegenerative diseases and validate diagnostic tools to identify people at risk. 
Meanwhile, healthcare decision-makers should start to pave the way for the advent of 
national programmes that facilitate earlier disease detection and intervention, with 
appropriate consideration of the ethical implications this would entail. To this end, the 
authors recommend that additional funding for research is provided in order to meet the 
goals listed below: 
 
• Improve our understanding of the underlying molecular mechanisms of the at-risk and pre- 
symptomatic phases of neurodegenerative disease 
• Increase our understanding of diagnostic and progression markers, particularly during the 
pre-symptomatic and prodromal phases, to help to track the disease course and severity 
• Identify the effectiveness and cost-effectiveness of interventions to promote brain health 
• Identify which tests for disease detection and diagnosis have optimal accuracy, availability 
and affordability 
• Assess the relative weight of different risk factors (e.g. lifestyle, genetic and molecular 
factors) and the interactions between them, so that decision-makers can decide how to 
prioritize them and address them 
• Understand the extent to which an individual’s awareness that he or she has strong risk 
factors for a neurodegenerative disease may motivate them to change their behaviour, and 
how best to support that behaviour change 
• Agree on policy and recommendations about the appropriate support required for a tested 
individual before and after a health check 
• Investigate the risk and protective factors involved in specific neurodegenerative diseases 
and neurodegeneration in general, at both the individual and societal level (e.g. by 
improving infrastructure and social capital) 
• Develop, validate and approve tests, tools and apps for monitoring brain health at an 
individual level by working in collaboration with regulatory authorities and stakeholder 
groups, including researchers, clinicians and funding bodies 
• Ensure that data from research are made publicly available and pooled to maximise their 
usefulness in developing the best diagnostic tools and treatments 
• Ensure that research results are provided, in a sensitive manner, to study participants, and 
that appropriate support is given. 
Actions to avert a future crisis 
Neurodegenerative diseases pose an enormous socioeconomic and individual burden, and this 
will continue to grow. To avert a crisis, the following recommendations are made: 
 
• Individuals should start to look after their brain health now and to change their behaviour to 
improve their chances of healthy ageing 
• Health professionals should educate the public about safeguarding their brain health 
• Public authorities should provide general health recommendations that include the benefits 
for brain health 
• Administrators of healthcare systems should ensure timely access to available interventions 
and services 
• Budget holders in relevant organisations should plan now to conduct research that will 
inform healthcare service design and delivery, so as to optimise disease diagnosis and 







• Researchers should investigate the best ways for health professionals to tell people the 
results of risk assessments or diagnoses in a timely and sensitive manner 
• Researchers should investigate further the most appropriate and effective biomarkers and 
treatments. 
Implications for clinical practice 
The knowledge and recommendations contained within this publication will help to facilitate 
the ongoing collaborative planning and management of health and social care systems 
favoured by policy documents such as NHS England’s Five Year Forward View (NHS 
England, 2014). In the subsequent document, Delivering the Forward View: NHS Planning 
Guidance 2016/17—2020/21, health services are required to design a ‘Sustainability and 
Transformation Plan’ that includes considering primary care services, social care and 
prevention of disease (NHS England, 2015). Dementia is mentioned specifically: at a 
minimum, two-thirds of people with dementia should have a diagnosis (NHS England, 2015) 
and, by implication, access to appropriate services. While these documents reflect plans for 
NHS England, the Think Brain Health Report makes recommendations that can be 
applied to healthcare systems across the world. 
 
There is a clear role for nurses in delivery of many of the policy recommendations detailed in 
Time matters: a call to prioritize brain health. The first step towards succeeding in this is to 
be aware of the recommendations and share them with colleagues. Following this, nurses 
should be prepared to take the lead in pushing for implementation of new ideas. Many 
policy documents are published every year, with resources of time and money poured into 
their development—but how many actually make a significant difference to patient 
outcomes? 
 
This is where strong nurse leadership is needed to embrace forward-thinking and innovative 
ideas that will positively affect services and patients, and to be prepared to fight for them at 
local and national levels, with the same passion with which we care for our patients every 
day. To follow in Florence’s footsteps. 
 
The report is 
 
Key points: 3-4 bullet points summarising the article 
This article has summarised and presented the contents of ‘Time matters: a call to 
prioritize brain health’ report. This document written by leading figures linked to 
neurodegenerative disease. The report call for individuals, health practitioners and 
policy makers to promote brain health, consider the judicious use of risk assessment 
and conduct research that will inform healthcare service design and delivery, all in order 
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